Sponsored Content

Good Night, Sleep Tight with affron® Natural Melatonin Booster

12 Mar 2024

Pure, clean-label support for natural melatonin production from Pharmactive Biotech’s saffron extract

Madrid – Results of a new study demonstrate that the standardized affron® saffron extract boosts the body’s endogenous production of melatonin. Melatonin—nicknamed the “sleep hormone”—is naturally produced in the body from the dietary amino acid tryptophan. Among other roles, melatonin helps synchronize the sleep–wake cycle and other circadian rhythms and helps adjust for seasonal changes in sleep timing. It has become one of the most commonly used treatment for sleep disorders.

Pharmactive Biotech Products, SLU, owners, and manufacturer of affron brand natural saffron ingredient, prized for, for its action in maintaining positive mood, induce relaxation, improve occasional stress, and mitigating psychological symptoms of menopause, announces results of a new in vivo study that shows that affron® can help boost the body’s endogenous production of melatonin.

“Results of a previous clinical study showed that Pharmactive’s potent saffron extract significantly improves sleep quality, helps to support mood balance after awakenings, reduce sleep-onset latency, ease difficulties in falling asleep, and allow for more continuous and less-interrupted slumber,” says Alberto Espinel, Open Innovation & IP Director. “The new study clarifies the mechanism for affron’s positive effects on sleep, providing solid scientific support to the previous studies.”

The placebo-controlled animal study was designed to assess of the effects of affron on melatonin synthesis and the Kynurenine Pathway. Melatonin is a hormone that is synthesized in the pineal gland from tryptophan (only a very minor part of the available tryptophan is used for melatonin synthesis), which is first converted into serotonin—the so-called “feel-good” hormone—and finally into melatonin.

Good Night, Sleep Tight with affron® Natural Melatonin Booster

Tryptophan also can follow another pathway and be enzymatically transformed into several molecules on the kynurenine pathway. This unbalanced pathway is negatively involved in several biological processes. The results of the new study indicate that affron® inhibits the enzymes that allow this conversion from tryptophan to kynurenine metabolites, demonstrating the antioxidant and anti-inflammatory properties of affron, while promoting the synthesis of enzymes responsible for transforming tryptophan into melatonin, resulting in a significative improvement of plasma melatonin levels.

In summary, the study shows unequivocally that affron has an effect on sleep quality because it stimulates endogenous melatonin production. Furthermore, it was observed throughout this process that the consumption of affron is safe and has no toxic effects on the body.

Lack of sleep has long been recognized by the US National Institutes of Health as a global crisis, a situation only exacerbated by the recent pandemic. A number of surveys suggest some two thirds of people report getting insufficient sleep. Insufficient Sleep is defined by The Sleep Foundation as “curtailed sleep that persists for three months or longer,” as well as “poor sleep that occurs because of sleep fragmentation or other disruptions.”

Long-term sleep deficit (defined as fewer than seven hours per night)—which now affects around a third of adults—has been linked to a host of physical, cognitive, and emotional diseases and dysfunctions that range from increased risks of obesity, high blood pressure, diabetes to heightened levels of occasional stress and low mood.

Twice as many persons are taking daily sleep aids as there were in 2010, according to the Centers for Disease Control, and in the past five years, melatonin has been increasingly favored by consumers as an aid to better slumber. Used as directed, melatonin is a safe and effective, natural supplement that can help users fall asleep more quickly and to get longer, and better quality, sleep. However, a study published last spring in the Journal of the American Medical Association revealed that nearly nine in 10 melatonin supplements were mislabelled, having inaccurately presented amounts of the hormone and some having none whatsoever.

The primary conclusion of the new in vivo study is that, with affron, the body can more efficiently generate its own melatonin without the need for melatonin supplements.

This is positive because it benefits population groups that do not metabolize exogen melatonin properly, such the elderly. Yet affron also is safe and effective for use by teenagers, making it a perfect ally for treating occasional sleeplessness in this often sleep-deprived age group. Moreover, no negative effects such as headaches, dizziness, drowsiness, etc. were observed.

“Better sleep is as much about good sleep as it is about duration of sleep,” explains Espinel. “Supported by previous studies on affron's ability to act as a natural sleeping agent, this latest study demonstrates that it is actively involved in aiding the body’s natural capacity to fall asleep and stay asleep.”

Pharmactive works with selected saffron farmers, supporting local and sustainable agriculture to ensure that the stigmas of Crocus sativus L. used are always of the highest quality. Their craft has been part of their cultural heritage for centuries and consists of traditional methods that bring unique characteristics to the final product. The fresh stigmas are dried on-site, immediately after harvesting, to ensure maximum stability of the active ingredients.

Affron® is naturally extracted from saffron via a proprietary extraction process AFF®ON Cool-Tech, using zero chemicals, with less energy and less industrial processing, using only water. Furthermore, thanks to the exhaustive quality controls carried out, it is possible to certify that the saffron used for the production of affron is 100% Crocus sativus L. It is water-soluble and versatile across multiple applications at a recommended daily amount of 28mg for improving mood and occasional stress, and 14mg one hour before bedtime to improve sleep quality.

About Pharmactive

Pharmactive Biotech Products, SLU, is a Madrid-based pioneering biotechnology company that develops and manufactures differentiated natural ingredients supported by science, such as damiana extract, pure saffron extract, and aged black garlic. The company’s mission is to make a daily positive and significant impact on people’s health and well-being through premium botanical ingredients backed by scientific studies and approved by ethics committees.

Read More

Related news

PharmaLinea’s iron supplement delivers improvements in  hemoglobin comparable to ferrous sulfate with fewer side  effects

PharmaLinea’s iron supplement delivers improvements in hemoglobin comparable to ferrous sulfate with fewer side effects

23 Feb 2026

PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.

Read more 
LomaChelateX® – power in magnesium bisglycinate

LomaChelateX® – power in magnesium bisglycinate

12 Feb 2026

Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.

Read more 
Fucoidan leader reports record production

Fucoidan leader reports record production

22 Jan 2026

The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.

Read more 
India Honours Ashwagandha with Commemorative  Postal Stamp at WHO Global Summit

India Honours Ashwagandha with Commemorative Postal Stamp at WHO Global Summit

6 Jan 2026

HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...

Read more 
PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

22 Dec 2025

PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...

Read more 
FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

11 Dec 2025

Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...

Read more 
dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

11 Dec 2025

Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025  dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...

Read more 
Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

11 Dec 2025

Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...

Read more 
Fucoidan specialist takes out top international health award

Fucoidan specialist takes out top international health award

4 Dec 2025

Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.

Read more 
Prayon inaugurates its new SHMP production unit in Engis

Prayon inaugurates its new SHMP production unit in Engis

1 Dec 2025

Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market

Read more